CODX vs COP
Co-Diagnostics, Inc. Common Stock (CODX) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
CODX currently screens at market cap $31.4M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the CODX and COP stock pages for the full models.
Not investment advice.